$AMGN
$AMGN
Amgen
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The companys principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçets disease; Prolia to treat postmenopausal women with ...
Stocks
Non-U.S. Investor
$20,380
▲+5.37%from 30d ago
$337
74
▲+8.82%from 30d ago
$597.47K
▲+778.93%from 30d ago
Amgen Metrics
Metric
Show % of Total
Tokenized Public Stocks
10 TotalRWA.xyzAll Rights Reserved